%20(1).webp)
For many years, the story of ADHD services in England has been one of growing demand outpacing available capacity. Waiting lists measured in years rather than months. Postcode lotteries. Adults who have struggled for decades finally seeking help and being told they will have to wait years more.
A BBC investigation, using freedom of information requests to survey 59 ADHD services across England, has revealed that the situation is now considerably worse than most previously understood. It is not only that waiting times have grown. In a significant number of areas, patients cannot even join a waiting list. The door to assessment has been closed entirely.
This is a new and more acute phase of a crisis that has been building for some time. Understanding what has happened, why it has happened, and what it means for people who need assessment requires looking at both the immediate findings and the structural conditions that produced them.
Through a freedom of information exercise surveying 59 ADHD services across England, the BBC has documented that the ADHD assessment crisis has entered a new and more severe phase. It is no longer only a question of how long people wait. In many areas, people are no longer able to join a waiting list at all.
The findings reveal a system that is, in many parts of England, effectively unable to accept new patients. Services that were already under significant strain have reached a point where they cannot ethically or safely continue adding names to lists that are already many years long. The result is that patients who present to their GPs with genuine, impairing ADHD symptoms are finding that no pathway to assessment exists in their area.
This is not a temporary or localised problem. It is a systemic failure playing out across the country, with significant variation by region and significant human consequences for the people it affects.
The BBC investigation found that of the 59 services surveyed across England, fifteen local areas have closed their ADHD waiting lists entirely, refusing to accept new referrals. A further thirty-one areas have introduced stricter referral criteria, limiting who can be referred and thereby excluding a significant proportion of people who would previously have been eligible.
Some of the most striking individual examples include Cheshire, where the adult ADHD service has been closed to new patients since 2019. Some areas serve large regions but have closed only specific localities, creating a postcode lottery in which access to assessment depends heavily on where you happen to live rather than on your clinical need.
NHS England's own figures already showed average adult ADHD waits of around eight years for those who managed to get onto a list. The latest findings reveal that this figure, concerning as it was, did not capture the full scale of the problem. For a significant and growing number of people, the wait is not eight years. It is indefinite, because no access point currently exists.
Several interconnected factors have produced the current crisis, and understanding them is important because they point to where solutions need to be directed.
Greater public awareness has significantly increased demand. Public conversations about ADHD, improved representation in media and social media, and the general shift in how the condition is discussed have helped more people recognise symptoms in themselves and their children and seek assessment. This is a positive development in terms of stigma reduction. It has produced a demand that services were not resourced to meet.
Reduced stigma has made it more possible for people to seek help. Again, this is a genuinely positive change. It has compounded the demand challenge.
Workforce shortages are a structural bottleneck. Specialist ADHD teams are small, and many areas rely on a very limited number of trained staff. The specialist workforce cannot be rapidly scaled, and without it, additional demand cannot be absorbed.
Historical structural underfunding is perhaps the most fundamental issue. Adult ADHD services in particular have long been inconsistently commissioned across regions. Services were designed and resourced for a patient population that was understood to be smaller and younger than it actually is. ADHD has always been present in the population at the rates now being identified. What has changed is society's recognition of this, and the services have not been built to reflect that recognition.
Dr Jessica Eccles of the Royal College of Psychiatrists described the situation directly: rising demand is outstripping capacity, leaving services to make difficult decisions about who they can safely support.
Statistics communicate scale. Individual accounts communicate what is actually at stake.
Louise Nichols, from Derbyshire, has struggled with ADHD-related difficulties since childhood. These difficulties have affected her education, her work, and her daily life. She sought assessment believing, reasonably, that a formal diagnosis could help her access the right support.
Her area had no local service, so she was placed on a neighbouring region's waiting list. When that trust stopped assessing people from outside its own borders, she was removed from the list entirely. She became one of more than 3,700 people in her county who found themselves without any route to diagnosis.
"It's really disappointing," she said. "I can't understand why a national health service isn't across the whole nation."
Her experience is not unusual. It is the direct, concrete consequence of a postcode lottery in which the provision of a nationally recognised health condition is entirely dependent on geography. Two people with identical symptoms and identical needs can have entirely different experiences of the healthcare system depending on which Integrated Care Board area they happen to live in.
The implications of being unable to access an ADHD assessment, or of waiting years to do so, are not administrative. They are clinical and personal.
ADHD affects how the brain regulates attention, impulse control, and emotional responses. Without diagnosis, individuals cannot access medication that for many is genuinely transformative. They cannot access the workplace or educational accommodations they are legally entitled to under the Equality Act 2010. They cannot access psychological support that is targeted to their actual condition. And they cannot benefit from the psychoeducation that changes how people understand their own behaviour and enables a shift from self-blame to effective management.
The consequences of unmanaged ADHD extend across every domain of daily life. Mental health difficulties including anxiety and depression are significantly more common in people with unrecognised or unmanaged ADHD. The NHS taskforce report has highlighted wider associations with substance misuse, higher unemployment, difficulties maintaining relationships, and greater involvement with the criminal justice system. These are not peripheral concerns. They are the measurable human cost of a system that cannot meet clinical need.
Professor Anita Thapar, chair of NHS England's ADHD taskforce, described the BBC investigation's findings as disturbing and emphasised what she called the enormous risks faced by patients who go without support.
Her taskforce report, released in the same period as the BBC investigation, paints a picture consistent with the structural analysis above: widespread under-diagnosis, widespread under-treatment, and a healthcare system that has not kept pace with the research evidence or with the scale of clinical need. The report calls for fundamental changes in how ADHD care is provided, extending its scope beyond health services into education and the criminal justice system.
This is significant. It is not only a health system problem. ADHD's impacts cross institutional boundaries, and the solutions need to do the same.
In some parts of England, the situation has escalated beyond complaint and advocacy to legal action.
In Coventry and Warwickshire, adult ADHD assessments were temporarily restricted to only those under twenty-five, leaving adults over that age with no NHS pathway to assessment. The Integrated Care Board faced a legal challenge from the charity ADHD UK as a consequence. For more on this specific case and its implications, see our article on the NHS board suspension of ADHD referrals.
The Right to Choose pathway, which has been one of the most effective mechanisms for improving access by allowing patients to choose from a wider range of providers, has also come under pressure from proposed policy changes that would significantly restrict each provider's patient numbers. For more on those changes and their implications, see our article on the Right to Choose latest updates.
These legal challenges are not simply about individual access. They are about establishing what an NHS that takes ADHD seriously is legally and ethically required to provide.
While the overall picture is one of services closing and waiting lists growing, it is worth acknowledging that some areas are developing genuinely promising responses to the challenge.
In Surrey, where more than eleven thousand adults are waiting for assessment, a pilot scheme has been developed that trains GPs to conduct ADHD assessments and provide ongoing care. The rationale is straightforward: small specialist teams cannot scale quickly enough to meet current demand, but the workforce of community NHS clinicians, particularly GPs, is considerably larger and more accessible if it can be equipped with the right training and support.
This model, if it can be implemented safely and effectively at scale, could meaningfully expand assessment capacity without requiring the kind of massive new specialist infrastructure that would take years to build. The questions are about training quality, clinical governance, and the support systems that GPs would need to carry out assessments to the standard that NICE guidelines require. For more on what high-quality ADHD training for clinicians involves, see our article on ADHD training for professionals.
Sam Stone, 33, spent years cycling through mental health services without resolution. Repeated courses of antidepressants. Persistent difficulties that were not adequately explained or addressed. Eventually, through a complicated pathway that included a private assessment via insurance and a subsequent NHS confirmation process, he received an ADHD diagnosis.
He describes the relief as "massive," like a long-standing cloud finally lifting. Not because diagnosis solved everything, but because it provided an accurate framework for understanding difficulties that had previously been explained through the wrong lens.
His journey also illustrates a problem that many people navigating the intersection of private assessment and NHS care will recognise: even after securing a private diagnosis, he had to return to NHS processes to have it confirmed before he could access NHS-funded medication. These kinds of disconnects between private assessment and NHS follow-up care are a significant and unnecessary barrier in the current system.
For more on the shared care arrangements that govern how medication is managed across private and NHS pathways, see our article on shared care agreements for ADHD medication.
Because NHS waiting lists are so long and, in many areas, now closed to new patients, an increasing proportion of people who can afford it are turning to private providers. This has created a visible and growing two-tier system: those with the financial means to access private care receive timely assessment and, with it, timely access to treatment, while those without those means wait years or have no pathway at all.
This is a significant equity issue. ADHD does not disproportionately affect people who can afford private healthcare. It affects people across all income levels. When access to a common, impairing, and treatable condition is effectively determined by financial means, that is a failure of the principle of universal healthcare, not only an administrative inconvenience.
The answer is not to restrict private provision, which is meeting genuine need in the absence of adequate NHS capacity. The answer is to build NHS capacity to the point where private provision is a genuine choice rather than the only option for those who cannot wait indefinitely.
The BBC investigation and the taskforce report together paint a picture of what is needed, and the broad shape of the necessary response is reasonably clear even if the implementation will be complex and resource-intensive.
Long-term investment is required. Demand for ADHD assessment is not going to decrease. Building the services to meet that demand requires resource commitment at a level that has not historically been applied to ADHD care.
National consistency needs to be restored. The postcode lottery that currently determines whether a patient can access any assessment pathway is neither clinically justifiable nor consistent with the principles of a national health service.
Broader workforce involvement needs to be developed systematically. The Surrey pilot points in the right direction. Training more clinicians, including GPs, pharmacists, and community mental health professionals, to conduct ADHD assessments and provide ongoing care is the most practical route to meaningfully expanding capacity without waiting for specialist teams to be built from scratch.
Clearer, simpler pathways are essential. Patients should not need to understand the fine detail of NHS commissioning policy, Right to Choose legislation, or shared care agreements in order to access a diagnosis for one of the most common neurodevelopmental conditions in the population.
And the interface between private assessment and NHS ongoing care needs to be significantly improved, so that patients who are assessed privately do not face the additional barrier of having to re-enter NHS processes to access medication and follow-up support.
The pattern that the BBC investigation has revealed is one that clinicians working in this space have been observing and raising concerns about for some time. The gap between what the research shows about ADHD and what the healthcare system is resourced to provide has been widening for years. What has changed is that it has now reached a point of visible systemic failure, with waiting lists closed and patients unable to access any pathway.
The most practical and immediately actionable component of the response is the expansion of training, so that more clinicians are equipped to contribute to assessment capacity. The Surrey pilot is one model. Other models are possible. What they share is the recognition that the specialist workforce alone cannot meet current demand, and that building broader clinical capability is the most realistic near-term route to improving access.
For healthcare professionals who want to develop their expertise in ADHD assessment and management, and thereby contribute to expanding the capacity the system urgently needs, our ADHD assessor training course and ADHD prescribing and management course provide CPD-certified education built around NICE guidelines and internationally recognised diagnostic frameworks.
If you are currently trying to access ADHD assessment, your first step is to speak to your GP about what pathways are currently available in your area. Specifically ask about the Right to Choose pathway and whether it is operational in your region. Ask what the current waiting time is for local services. Ask whether there is a neighbouring area's service that may still be accepting referrals.
If you have been told no pathway exists in your area, ask your GP to document this and ask specifically about Individual Funding Requests, which in some cases can fund access to alternative providers. Contact your local patient advocacy service for guidance on your options.
If you are considering private assessment, choose a provider that is CQC-registered, employs qualified and registered clinicians, conducts comprehensive assessments aligned with NICE guidelines, and can clearly explain what ongoing care including medication management will look like after diagnosis. For more on navigating the private pathway and shared care, see our articles on private ADHD clinics and shared care agreements.
If you are currently on a waiting list, the Right to Choose pathway may still allow you to transfer to a provider with a shorter wait. Ask your GP whether this remains an option.
If you are a clinician who wants to contribute to expanding the capacity the system needs, developing your ADHD assessment expertise is the most direct way to do so. The demand is real, the clinical need is documented, and trained clinicians who can safely and competently conduct ADHD assessments are urgently needed.
Why are NHS ADHD waiting lists being closed?
Services have reached a point where they cannot ethically or safely continue adding to lists that are already many years long. The combination of surging demand, driven primarily by increased awareness rather than increased prevalence of ADHD, and insufficient specialist workforce and resources has created a situation where services have no capacity to absorb new referrals.
If there is no waiting list in my area, what can I do?
Ask your GP about the Right to Choose pathway, which allows referral to providers outside your immediate area. Ask about Individual Funding Requests if no local pathway exists. Consider private assessment if you are able to access it. Contact your local patient advocacy service for guidance.
Is Right to Choose still available?
Right to Choose availability has been subject to changes and varies by region. Some areas maintain it, others have seen it restricted. Your GP should be able to advise on the current status in your area.
Can I access ADHD medication without an NHS assessment?
In most cases, no. ADHD medication requires a formal specialist diagnosis. A private assessment can provide the diagnosis needed, but accessing medication through NHS prescribing typically then requires a shared care agreement with your GP, which is not always straightforward to establish.
What is the NHS taskforce doing about this?
The NHS England ADHD taskforce, chaired by Professor Anita Thapar, has published a report calling for fundamental changes to how ADHD care is provided, including expanded capacity, improved training, and better coordination across health, education, and the criminal justice system. The recommendations are substantive, but implementation will require sustained resource commitment.
How long is the average NHS ADHD wait?
NHS England's own figures indicate average waits of around eight years for adults who have managed to get onto a waiting list. In some areas the wait is longer. In fifteen areas surveyed by the BBC, there is currently no waiting list to join.
The BBC investigation has made visible something that many patients, clinicians, and patient advocates have known for some time: ADHD services in England are not failing to keep pace with demand. In a significant number of areas, they have reached a point of effective collapse, with waiting lists closed and patients unable to access any pathway to assessment.
This is not a minor operational problem. It is a systemic failure with real, measurable consequences for the mental health, employment, relationships, and daily functioning of the people it affects. The taskforce report's description of the situation as carrying enormous risks for patients is not an exaggeration.
The path forward requires long-term investment, national consistency, expanded workforce training, and a genuine commitment to ensuring that access to diagnosis and treatment for one of the most common neurodevelopmental conditions in the population does not depend on your postcode, your income, or your ability to navigate a fragmented and overwhelmed system.
Until those structural changes are in place, patients deserve clear information about the options that remain available to them, and clinicians deserve accessible training that enables them to contribute to meeting the need their patients are presenting with.
Medical Disclaimer
This article is intended for educational and informational purposes only. It does not constitute medical or legal advice. Information about NHS services and waiting times reflects the situation at time of writing and may have changed. Always consult a qualified healthcare professional for personalised guidance.
